Goldman Sachs’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-73,522
| Closed | -$1.33M | – | 4887 |
|
|
2020
Q3 | $1.33M | Sell |
73,522
-39,275
| -35% | -$713K | ﹤0.01% | 3142 |
|
|
2020
Q2 | $1.55M | Buy |
112,797
+46,232
| +69% | +$633K | ﹤0.01% | 2978 |
|
|
2020
Q1 | $952K | Sell |
66,565
-18,979
| -22% | -$271K | ﹤0.01% | 3149 |
|
|
2019
Q4 | $1.45M | Buy |
85,544
+21,651
| +34% | +$367K | ﹤0.01% | 3126 |
|
|
2019
Q3 | $983K | Buy |
63,893
+12,621
| +25% | +$194K | ﹤0.01% | 3262 |
|
|
2019
Q2 | $1.2M | Sell |
51,272
-765
| -1% | -$17.9K | ﹤0.01% | 3079 |
|
|
2019
Q1 | $1.47M | Buy |
52,037
+1,470
| +3% | +$41.6K | ﹤0.01% | 3088 |
|
|
2018
Q4 | $1.53M | Buy |
50,567
+3,734
| +8% | +$113K | ﹤0.01% | 2922 |
|
|
2018
Q3 | $1.64M | Sell |
46,833
-17,270
| -27% | -$605K | ﹤0.01% | 2967 |
|
|
2018
Q2 | $1.52M | Buy |
64,103
+20,326
| +46% | +$482K | ﹤0.01% | 3003 |
|
|
2018
Q1 | $1.12M | Buy |
43,777
+9,314
| +27% | +$239K | ﹤0.01% | 3140 |
|
|
2017
Q4 | $598K | Buy |
+34,463
| New | +$598K | ﹤0.01% | 3372 |
|